Close Menu

Beckman Coulter

The $800 million acquisition will strengthen Beckman Coulter's presence in the clinical chemistry market. The firm does not anticipate a change in its current investment grade ratings due to the new debt.

IP Roundup: Feb 24, 2009

Premium

CalTech, Beckman Coulter, Genisphere, Seiko Epson

Included is a paper on the use of a mass spectrometry-based strategy for the absolute quantification of protein complex components, one using SISCAPA technology, and one showing that top-down proteomics can be done using CID on a q-TOF instrument.

News Scan: Feb 13, 2009

Premium

Trevena, Ligand Pharmaceuticals, Ibidi, Seahorse Bioscience

Regardless of the outcome of the first phase of the trial, Life Technologies declared victory last week, saying that the patents are irrelevant for current or future versions of the SOLiD technology.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.